Massive Bio, a global precision oncology company, today announced the publication of a peer-reviewed prospective study in ...

Follow-up overall survival, months, median (range) 96 (15-120) Follow-up PSA to recurrence or death, months, median (range) 55 (11-111) Follow-up PSA patients alive and recurrence-free, months, median ...

Clinical decision making by ChatGPT vs medical oncologists: A retrospective concordance study. Investigating large language model (LLM) performance using in-context learning (ICL) for interpretation ...

First-degree relatives experienced an MS incidence of 211 per 100,000 per year, roughly 100-fold above sporadic MS rates, with median 2-year time to conversion and diagnosis at 37. Evolving ...

Objective To investigate the association between sprint running biomechanics and sprint-related hamstring strain injury (HSI) in elite male football players. Methods This prospective cohort study ...

Noninferiority study meets criteria for superiority ...

A new meta-analysis of prospective studies finds artificial intelligence performs similarly to dermatologists in melanoma ...

Objective To examine the associations of accelerometer-measured physical activity and sedentary time with all-cause mortality in older Japanese adults. Methods A total of 1723 independent Japanese ...

A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care without invasive surgery.

Prospective evidence supports SABR as a valid option for localized RCC and suggests SABR with or without immunotherapy has promise in the metastatic setting. Challenging notions of renal cell ...